Literature DB >> 23095990

A validated bowel-preparation tolerability questionnaire and assessment of three commonly used bowel-cleansing agents.

I C Lawrance1, R P Willert, K Murray.   

Abstract

BACKGROUND AND STUDY AIMS: Bowel-cleansing studies are frequently underpowered, poorly designed, and with subjective assessments. Consensus on tolerability of the bowel-cleansing agents is thus lacking. This study developed and validated a bowel-preparation tolerability questionnaire and used it to assess the tolerability of three bowel-cleansing agents, sodium phosphate (NaP), polyethylene glycol (PEG), and sodium picosulphate (Pico), in a prospective randomized single-blinded trial of ambulatory patients. PATIENTS AND METHODS: The bowel-preparation tolerability questionnaire was validated in 125 consecutive patients and then bowel-preparation agent tolerability was assessed in 634 patients in a prospective randomized single-blinded trial.
RESULTS: The questionnaire's internal consistency was satisfactory with good to excellent "test-retest" reliability for aggregate tolerability and visual analogue scores. Validity assessment confirmed it as reliable and accurate. Of 634 patients, 97.8 % took >75 % of the allocated preparation and 98.9 % completed the questionnaire. Overall, Pico was better tolerated than PEG (p < 0.001) and NaP (p < 0.001). NaP was better tolerated than PEG (p < 0.001). Regardless of the bowel-preparation agent used, males tolerated them better than females (p = 0.009) as did patients having their procedure in the AM. Older patients, however, tolerated all preparations better than younger patients (p = 0.006).
CONCLUSIONS: This study used the first validated bowel-preparation tolerability questionnaire and identified that age, sex, and procedure time all impacted tolerability. Overall, Pico was best tolerated, but PEG's tolerability in patients ≥60 years was equal to that of Pico and NaP, suggesting that PEG can be recommended for older patients to avoid the electrolyte disturbances associated with the osmotic preparations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23095990     DOI: 10.1007/s10620-012-2449-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

Review 1.  Systematic review: oral bowel preparation for colonoscopy.

Authors:  J Belsey; O Epstein; D Heresbach
Journal:  Aliment Pharmacol Ther       Date:  2007-02-15       Impact factor: 8.171

2.  Does colonoscopy cause increased ulcerative colitis symptoms?

Authors:  Stacy Menees; Peter Higgins; Sheryl Korsnes; Grace Elta
Journal:  Inflamm Bowel Dis       Date:  2007-01       Impact factor: 5.325

3.  Cleansing ability and tolerance of three bowel preparations for colonoscopy.

Authors:  D Frommer
Journal:  Dis Colon Rectum       Date:  1997-01       Impact factor: 4.585

4.  Bowel cleansing for colonoscopy: prospective randomized assessment of efficacy and of induced mucosal abnormality with three preparation agents.

Authors:  I C Lawrance; R P Willert; K Murray
Journal:  Endoscopy       Date:  2011-05-04       Impact factor: 10.093

5.  A prospective, observational study of colonic mucosal abnormalities associated with orally administered sodium phosphate for colon cleansing before colonoscopy.

Authors:  Stanislav Rejchrt; Jan Bures; Milan Siroký; Marcela Kopácová; Lubos Slezák; Frantisek Langr
Journal:  Gastrointest Endosc       Date:  2004-05       Impact factor: 9.427

6.  Bowel preparation for colonoscopy: a randomized controlled trial comparing polyethylene glycol solution, one dose and two doses of oral sodium phosphate solution.

Authors:  Wai-Lun Law; Hok-Kwok Choi; Kin-Wah Chu; Judy W C Ho; Lucia Wong
Journal:  Asian J Surg       Date:  2004-04       Impact factor: 2.767

7.  A randomised controlled trial of a new 2 litre polyethylene glycol solution versus sodium picosulphate + magnesium citrate solution for bowel cleansing prior to colonoscopy.

Authors:  J Worthington; M Thyssen; G Chapman; R Chapman; M Geraint
Journal:  Curr Med Res Opin       Date:  2008-02       Impact factor: 2.580

8.  Randomized trial of low-volume PEG solution versus standard PEG + electrolytes for bowel cleansing before colonoscopy.

Authors:  Christian Ell; Wolfgang Fischbach; Hans-Joachim Bronisch; Stefan Dertinger; Peter Layer; Michael Rünzi; Thomas Schneider; Günther Kachel; Jörg Grüger; Michael Köllinger; Waltraud Nagell; Karl-Josel Goerg; Roland Wanitschke; Hans-Jürgen Gruss
Journal:  Am J Gastroenterol       Date:  2008-01-11       Impact factor: 10.864

9.  Oral sodium phosphate (Fleet) is a superior colonoscopy preparation to Picopre (sodium picosulfate-based preparation).

Authors:  Joe J Tjandra; Miranda Chan; Peter P Tagkalidis
Journal:  Dis Colon Rectum       Date:  2006-05       Impact factor: 4.585

10.  Picoprep-3 is a superior colonoscopy preparation to Fleet: a randomized, controlled trial comparing the two bowel preparations.

Authors:  Liu-Ming Schmidt; Pamela Williams; Denis King; Dayashan Perera
Journal:  Dis Colon Rectum       Date:  2004-02       Impact factor: 4.585

View more
  8 in total

1.  Prospective, randomized comparison of same-day dose of 2 different bowel cleanser for afternoon colonoscopy: picosulfate, magnesium oxide, and citric acid versus polyethylene glycol.

Authors:  Tae-Geun Gweon; Sang Woo Kim; Yong-Sun Noh; Seawon Hwang; Na-Young Kim; Yoonbum Lee; Soon-Wook Lee; Sung Won Lee; Jong Yul Lee; Chul-Hyun Lim; Hyung Hun Kim; Jin Su Kim; Yu Kyung Cho; Jae Myung Park; In Seok Lee
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

2.  Multicentre endoscopist-blinded randomised clinical trial to compare two bowel preparations after a colonoscopy with inadequate cleansing: a study protocol.

Authors:  Michael Sai Lai Sey; Daniel von Renteln; Richard Sultanian; Cassandra McDonald; Myriam Martel; Alan Barkun
Journal:  BMJ Open       Date:  2019-07-09       Impact factor: 2.692

3.  A Phase 2 Randomized Trial of DCL-101, a Novel Pill-Based Colonoscopy Prep, vs 4L Polyethylene Glycol-Electrolyte Solution.

Authors:  Dale R Bachwich; James D Lewis; Vera O Kowal; Brian C Jacobson; Audrey H Calderwood; Michael L Kochman
Journal:  Clin Transl Gastroenterol       Date:  2020-12       Impact factor: 4.396

4.  Prospective single-blinded single-center randomized controlled trial of Prep Kit-C and Moviprep: Does underlying inflammatory bowel disease impact tolerability and efficacy?

Authors:  Waled Mohsen; Astrid-Jane Williams; Gabrielle Wark; Alexandra Sechi; Jenn-Hian Koo; Wei Xuan; Milan Bassan; Watson Ng; Susan Connor
Journal:  World J Gastroenterol       Date:  2021-03-21       Impact factor: 5.742

5.  Efficacy and Tolerability of Two Different Low-Volume Split-Dose Polyethylene Glycol Electrolytes Solution Bowel Preparation for Morning Colonoscopy.

Authors:  Hefeng Tian; Hui Li; Xuanrui Zhu; Wenlong Liu; Ying Fan; Lei Shi; Xiu Wang
Journal:  Can J Gastroenterol Hepatol       Date:  2022-08-31

6.  Sodium Picosulfate with Magnesium Citrate (SPMC) Plus Laxative Is a Good Alternative to Conventional Large Volume Polyethylene Glycol in Bowel Preparation: A Multicenter Randomized Single-Blinded Trial.

Authors:  Hyun Gun Kim; Kyu Chan Huh; Hoon Sup Koo; Seong-Eun Kim; Jin-Oh Kim; Tae Il Kim; Hyun-Soo Kim; Seung-Jae Myung; Dong Il Park; Jeong Eun Shin; Dong-Hoon Yang; Suck-Ho Lee; Ji Sung Lee; Chang Kyun Lee; Dong Kyung Chang; Young-Eun Joo; Jae Myung Cha; Sung Pil Hong; Hyo Jong Kim
Journal:  Gut Liver       Date:  2015-07       Impact factor: 4.519

7.  Split- versus single-dose preparation tolerability in a multiethnic population: decreased side effects but greater social barriers.

Authors:  Gabriel Perreault; Adam Goodman; Sebastian Larion; Ahana Sen; Kirsten Quiles; Michael Poles; Renee Williams
Journal:  Ann Gastroenterol       Date:  2018-03-28

8.  A European, multicentre, observational, post-authorisation safety study of oral sulphate solution: compliance and safety.

Authors:  Jaroslaw Regula; Manon C W Spaander; Stepan Suchanek; Anne Kornowski; Valerie Perrot; Wolfgang Fischbach
Journal:  Endosc Int Open       Date:  2020-02-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.